GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-130a-3p
|
MIMAT0000425 |
hsa-miR-130b-3p
|
MIMAT0000691 |
hsa-miR-301a-3p
|
MIMAT0000688 |
hsa-miR-301b-3p
|
MIMAT0004958 |
hsa-miR-454-3p
|
MIMAT0003885 |
hsa-miR-3666
|
MIMAT0018088 |
hsa-miR-4295
|
MIMAT0016844 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_+_10199468 | 30.51 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr14_-_60097297 | 24.17 |
ENST00000395090.1
|
RTN1
|
reticulon 1 |
chr1_-_204380919 | 23.56 |
ENST00000367188.4
|
PPP1R15B
|
protein phosphatase 1, regulatory subunit 15B |
chr8_+_11141925 | 15.05 |
ENST00000221086.3
|
MTMR9
|
myotubularin related protein 9 |
chr17_-_78450398 | 14.80 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
chr11_-_113746277 | 14.25 |
ENST00000003302.4
ENST00000545540.1 |
USP28
|
ubiquitin specific peptidase 28 |
chr3_+_115342159 | 13.93 |
ENST00000305124.6
|
GAP43
|
growth associated protein 43 |
chr5_+_71403061 | 13.77 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
chr20_+_1246908 | 13.61 |
ENST00000381873.3
ENST00000381867.1 |
SNPH
|
syntaphilin |
chr3_+_50712672 | 13.46 |
ENST00000266037.9
|
DOCK3
|
dedicator of cytokinesis 3 |
chr14_-_21493884 | 13.03 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
chr19_+_47759716 | 12.70 |
ENST00000221922.6
|
CCDC9
|
coiled-coil domain containing 9 |
chr8_-_110660999 | 12.67 |
ENST00000424158.2
ENST00000533895.1 ENST00000446070.2 ENST00000528331.1 ENST00000526302.1 ENST00000433638.1 ENST00000408908.2 ENST00000524720.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
chr8_+_26435359 | 12.55 |
ENST00000311151.5
|
DPYSL2
|
dihydropyrimidinase-like 2 |
chr15_-_83316254 | 12.45 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr16_-_57318566 | 11.94 |
ENST00000569059.1
ENST00000219207.5 |
PLLP
|
plasmolipin |
chr11_-_45687128 | 11.83 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr17_-_27278304 | 11.07 |
ENST00000577226.1
|
PHF12
|
PHD finger protein 12 |
chr16_+_19125252 | 10.81 |
ENST00000566735.1
ENST00000381440.3 |
ITPRIPL2
|
inositol 1,4,5-trisphosphate receptor interacting protein-like 2 |
chr1_+_84543734 | 10.75 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr13_+_42846272 | 10.56 |
ENST00000025301.2
|
AKAP11
|
A kinase (PRKA) anchor protein 11 |
chr2_+_25015968 | 10.39 |
ENST00000380834.2
ENST00000473706.1 |
CENPO
|
centromere protein O |
chr19_-_17799008 | 10.33 |
ENST00000519716.2
|
UNC13A
|
unc-13 homolog A (C. elegans) |
chr22_-_21213029 | 9.97 |
ENST00000572273.1
ENST00000255882.6 |
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha |
chr20_-_48532019 | 9.70 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
chr15_-_49338748 | 9.66 |
ENST00000559471.1
|
SECISBP2L
|
SECIS binding protein 2-like |
chrX_+_53111541 | 9.58 |
ENST00000375442.4
ENST00000579390.1 |
TSPYL2
|
TSPY-like 2 |
chr18_-_65184217 | 9.21 |
ENST00000310045.7
|
DSEL
|
dermatan sulfate epimerase-like |
chr16_+_50775948 | 9.17 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr20_+_34700333 | 9.01 |
ENST00000441639.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chrX_-_92928557 | 8.90 |
ENST00000373079.3
ENST00000475430.2 |
NAP1L3
|
nucleosome assembly protein 1-like 3 |
chr14_+_74111578 | 8.83 |
ENST00000554113.1
ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1
|
dynein, axonemal, light chain 1 |
chr11_-_118661828 | 8.83 |
ENST00000264018.4
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
chr4_-_36246060 | 8.62 |
ENST00000303965.4
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr11_+_113930291 | 8.47 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr1_+_78245303 | 8.43 |
ENST00000370791.3
ENST00000443751.2 |
FAM73A
|
family with sequence similarity 73, member A |
chr5_-_136834982 | 8.35 |
ENST00000510689.1
ENST00000394945.1 |
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
chr9_+_99212403 | 8.33 |
ENST00000375251.3
ENST00000375249.4 |
HABP4
|
hyaluronan binding protein 4 |
chr17_-_1532106 | 8.31 |
ENST00000301335.5
ENST00000382147.4 |
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2 |
chr17_-_17875688 | 8.21 |
ENST00000379504.3
ENST00000318094.10 ENST00000540946.1 ENST00000542206.1 ENST00000395739.4 ENST00000581396.1 ENST00000535933.1 ENST00000579586.1 |
TOM1L2
|
target of myb1-like 2 (chicken) |
chr11_+_92085262 | 8.18 |
ENST00000298047.6
ENST00000409404.2 ENST00000541502.1 |
FAT3
|
FAT atypical cadherin 3 |
chr8_+_42752053 | 8.12 |
ENST00000307602.4
|
HOOK3
|
hook microtubule-tethering protein 3 |
chr11_-_46940074 | 8.11 |
ENST00000378623.1
ENST00000534404.1 |
LRP4
|
low density lipoprotein receptor-related protein 4 |
chr11_-_18656028 | 8.11 |
ENST00000336349.5
|
SPTY2D1
|
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae) |
chr2_-_2334888 | 8.06 |
ENST00000428368.2
ENST00000399161.2 |
MYT1L
|
myelin transcription factor 1-like |
chr6_-_154677900 | 8.05 |
ENST00000265198.4
ENST00000520261.1 |
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
chr17_-_19771216 | 7.95 |
ENST00000395544.4
|
ULK2
|
unc-51 like autophagy activating kinase 2 |
chr10_-_124768300 | 7.91 |
ENST00000368886.5
|
IKZF5
|
IKAROS family zinc finger 5 (Pegasus) |
chr13_+_53226963 | 7.90 |
ENST00000343788.6
ENST00000535397.1 ENST00000310528.8 |
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
chr5_-_138210977 | 7.82 |
ENST00000274711.6
ENST00000521094.2 |
LRRTM2
|
leucine rich repeat transmembrane neuronal 2 |
chrX_-_54384425 | 7.77 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr3_-_18466787 | 7.72 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
chrX_-_18372792 | 7.65 |
ENST00000251900.4
|
SCML2
|
sex comb on midleg-like 2 (Drosophila) |
chr15_+_31619013 | 7.62 |
ENST00000307145.3
|
KLF13
|
Kruppel-like factor 13 |
chr10_-_102279586 | 7.61 |
ENST00000370345.3
ENST00000451524.1 ENST00000370329.5 |
SEC31B
|
SEC31 homolog B (S. cerevisiae) |
chr1_-_109584608 | 7.61 |
ENST00000400794.3
ENST00000528747.1 ENST00000369962.3 ENST00000361054.3 |
WDR47
|
WD repeat domain 47 |
chr10_+_92980517 | 7.35 |
ENST00000336126.5
|
PCGF5
|
polycomb group ring finger 5 |
chr10_-_73611046 | 7.26 |
ENST00000394934.1
ENST00000394936.3 |
PSAP
|
prosaposin |
chr4_+_55524085 | 7.23 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chr6_-_136871957 | 7.22 |
ENST00000354570.3
|
MAP7
|
microtubule-associated protein 7 |
chr18_-_53255766 | 7.12 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
chr1_-_52831796 | 7.10 |
ENST00000284376.3
ENST00000438831.1 ENST00000371586.2 |
CC2D1B
|
coiled-coil and C2 domain containing 1B |
chr10_-_81205373 | 6.94 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr4_+_139936905 | 6.91 |
ENST00000280614.2
|
CCRN4L
|
CCR4 carbon catabolite repression 4-like (S. cerevisiae) |
chr6_+_56954867 | 6.65 |
ENST00000370708.4
ENST00000370702.1 |
ZNF451
|
zinc finger protein 451 |
chr20_+_57267669 | 6.60 |
ENST00000356091.6
|
NPEPL1
|
aminopeptidase-like 1 |
chr2_+_70142189 | 6.55 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
chr2_+_173600671 | 6.49 |
ENST00000409036.1
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr8_-_53322303 | 6.45 |
ENST00000276480.7
|
ST18
|
suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein) |
chr11_-_108093329 | 6.44 |
ENST00000278612.8
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus |
chr2_+_203879568 | 6.40 |
ENST00000449802.1
|
NBEAL1
|
neurobeachin-like 1 |
chr8_+_27631903 | 6.36 |
ENST00000305188.8
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2 |
chr1_-_226924980 | 6.35 |
ENST00000272117.3
|
ITPKB
|
inositol-trisphosphate 3-kinase B |
chr14_-_50698276 | 6.20 |
ENST00000216373.5
|
SOS2
|
son of sevenless homolog 2 (Drosophila) |
chr7_+_138916231 | 6.15 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr7_+_94139105 | 6.14 |
ENST00000297273.4
|
CASD1
|
CAS1 domain containing 1 |
chr2_+_149632783 | 6.14 |
ENST00000435030.1
|
KIF5C
|
kinesin family member 5C |
chr1_+_11866207 | 6.06 |
ENST00000312413.6
ENST00000346436.6 |
CLCN6
|
chloride channel, voltage-sensitive 6 |
chr19_-_10341948 | 5.92 |
ENST00000590320.1
ENST00000592342.1 ENST00000588952.1 |
S1PR2
DNMT1
|
sphingosine-1-phosphate receptor 2 DNA (cytosine-5-)-methyltransferase 1 |
chr11_-_74109422 | 5.81 |
ENST00000298198.4
|
PGM2L1
|
phosphoglucomutase 2-like 1 |
chr10_+_76871454 | 5.67 |
ENST00000372687.4
|
SAMD8
|
sterile alpha motif domain containing 8 |
chr3_+_4535025 | 5.61 |
ENST00000302640.8
ENST00000354582.6 ENST00000423119.2 ENST00000357086.4 ENST00000456211.2 |
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1 |
chr2_+_173940442 | 5.59 |
ENST00000409176.2
ENST00000338983.3 ENST00000431503.2 |
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
chr5_+_7396141 | 5.58 |
ENST00000338316.4
|
ADCY2
|
adenylate cyclase 2 (brain) |
chr9_+_100263912 | 5.53 |
ENST00000259365.4
|
TMOD1
|
tropomodulin 1 |
chr10_+_96162242 | 5.49 |
ENST00000225235.4
|
TBC1D12
|
TBC1 domain family, member 12 |
chr5_-_65017921 | 5.47 |
ENST00000381007.4
|
SGTB
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
chr17_+_16284104 | 5.35 |
ENST00000577958.1
ENST00000302182.3 ENST00000577640.1 |
UBB
|
ubiquitin B |
chr13_+_49822041 | 5.29 |
ENST00000538056.1
ENST00000251108.6 ENST00000444959.1 ENST00000429346.1 |
CDADC1
|
cytidine and dCMP deaminase domain containing 1 |
chr1_-_51984908 | 5.25 |
ENST00000371730.2
|
EPS15
|
epidermal growth factor receptor pathway substrate 15 |
chr2_-_86564776 | 5.24 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
chr6_+_44238203 | 5.16 |
ENST00000451188.2
|
TMEM151B
|
transmembrane protein 151B |
chr1_-_95538492 | 5.14 |
ENST00000370205.5
|
ALG14
|
ALG14, UDP-N-acetylglucosaminyltransferase subunit |
chr3_-_66551351 | 5.13 |
ENST00000273261.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
chr17_-_61777459 | 5.10 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
chr13_-_36920420 | 5.03 |
ENST00000438666.2
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome) |
chr1_+_97187318 | 4.94 |
ENST00000609116.1
ENST00000370198.1 ENST00000370197.1 ENST00000426398.2 ENST00000394184.3 |
PTBP2
|
polypyrimidine tract binding protein 2 |
chr6_+_121756809 | 4.84 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chr3_-_178790057 | 4.82 |
ENST00000311417.2
|
ZMAT3
|
zinc finger, matrin-type 3 |
chr10_-_104178857 | 4.77 |
ENST00000020673.5
|
PSD
|
pleckstrin and Sec7 domain containing |
chr14_-_96830207 | 4.76 |
ENST00000359933.4
|
ATG2B
|
autophagy related 2B |
chr7_-_139876812 | 4.67 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr2_-_101767715 | 4.63 |
ENST00000376840.4
ENST00000409318.1 |
TBC1D8
|
TBC1 domain family, member 8 (with GRAM domain) |
chr2_+_177053307 | 4.62 |
ENST00000331462.4
|
HOXD1
|
homeobox D1 |
chr18_+_54318616 | 4.61 |
ENST00000254442.3
|
WDR7
|
WD repeat domain 7 |
chr2_-_68694390 | 4.60 |
ENST00000377957.3
|
FBXO48
|
F-box protein 48 |
chr1_+_28099683 | 4.60 |
ENST00000373943.4
|
STX12
|
syntaxin 12 |
chr14_+_57857262 | 4.58 |
ENST00000555166.1
ENST00000556492.1 ENST00000554703.1 |
NAA30
|
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
chr5_-_133512683 | 4.56 |
ENST00000353411.6
|
SKP1
|
S-phase kinase-associated protein 1 |
chr12_+_120105558 | 4.53 |
ENST00000229328.5
ENST00000541640.1 |
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
chr4_+_86396265 | 4.53 |
ENST00000395184.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
chr11_+_14665263 | 4.50 |
ENST00000282096.4
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
chr18_+_9136758 | 4.41 |
ENST00000383440.2
ENST00000262126.4 ENST00000577992.1 |
ANKRD12
|
ankyrin repeat domain 12 |
chr22_+_50781723 | 4.40 |
ENST00000359139.3
ENST00000395741.3 ENST00000395744.3 |
PPP6R2
|
protein phosphatase 6, regulatory subunit 2 |
chr2_-_27718052 | 4.40 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
chr11_-_31839488 | 4.31 |
ENST00000419022.1
ENST00000379132.3 ENST00000379129.2 |
PAX6
|
paired box 6 |
chr9_-_79520989 | 4.26 |
ENST00000376713.3
ENST00000376718.3 ENST00000428286.1 |
PRUNE2
|
prune homolog 2 (Drosophila) |
chr14_-_75593708 | 4.25 |
ENST00000557673.1
ENST00000238616.5 |
NEK9
|
NIMA-related kinase 9 |
chr20_+_44657845 | 4.22 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr17_+_53342311 | 4.21 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
chr4_+_153701081 | 4.09 |
ENST00000451320.2
ENST00000429148.2 ENST00000353617.2 ENST00000405727.2 ENST00000356064.3 |
ARFIP1
|
ADP-ribosylation factor interacting protein 1 |
chr2_-_69870835 | 4.04 |
ENST00000409085.4
ENST00000406297.3 |
AAK1
|
AP2 associated kinase 1 |
chr1_-_38019878 | 4.03 |
ENST00000296215.6
|
SNIP1
|
Smad nuclear interacting protein 1 |
chr20_-_48099182 | 3.99 |
ENST00000371741.4
|
KCNB1
|
potassium voltage-gated channel, Shab-related subfamily, member 1 |
chr9_-_135819987 | 3.99 |
ENST00000298552.3
ENST00000403810.1 |
TSC1
|
tuberous sclerosis 1 |
chr2_-_47403642 | 3.96 |
ENST00000456319.1
ENST00000409563.1 ENST00000272298.7 |
CALM2
|
calmodulin 2 (phosphorylase kinase, delta) |
chr10_+_126490354 | 3.95 |
ENST00000298492.5
|
FAM175B
|
family with sequence similarity 175, member B |
chr9_-_136857403 | 3.89 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
chr11_-_46722117 | 3.88 |
ENST00000311956.4
|
ARHGAP1
|
Rho GTPase activating protein 1 |
chr17_+_54911444 | 3.87 |
ENST00000284061.3
ENST00000572810.1 |
DGKE
|
diacylglycerol kinase, epsilon 64kDa |
chr8_-_93115445 | 3.86 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr6_+_148663729 | 3.85 |
ENST00000367467.3
|
SASH1
|
SAM and SH3 domain containing 1 |
chr7_-_5821314 | 3.77 |
ENST00000425013.2
ENST00000389902.3 |
RNF216
|
ring finger protein 216 |
chr3_+_37493610 | 3.74 |
ENST00000264741.5
|
ITGA9
|
integrin, alpha 9 |
chr14_+_103851712 | 3.73 |
ENST00000440884.3
ENST00000416682.2 ENST00000429436.2 ENST00000303622.9 |
MARK3
|
MAP/microtubule affinity-regulating kinase 3 |
chr13_+_42622781 | 3.63 |
ENST00000337343.4
ENST00000261491.5 ENST00000379274.2 |
DGKH
|
diacylglycerol kinase, eta |
chr3_-_114790179 | 3.63 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr1_-_36022979 | 3.60 |
ENST00000469892.1
ENST00000325722.3 |
KIAA0319L
|
KIAA0319-like |
chr17_-_42580738 | 3.60 |
ENST00000585614.1
ENST00000591680.1 ENST00000434000.1 ENST00000588554.1 ENST00000592154.1 |
GPATCH8
|
G patch domain containing 8 |
chr2_+_241508039 | 3.53 |
ENST00000270357.4
|
RNPEPL1
|
arginyl aminopeptidase (aminopeptidase B)-like 1 |
chr19_-_4066890 | 3.53 |
ENST00000322357.4
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
chr4_-_53525406 | 3.52 |
ENST00000451218.2
ENST00000441222.3 |
USP46
|
ubiquitin specific peptidase 46 |
chrX_-_153363188 | 3.52 |
ENST00000303391.6
|
MECP2
|
methyl CpG binding protein 2 (Rett syndrome) |
chr17_+_41132564 | 3.45 |
ENST00000361677.1
ENST00000589705.1 |
RUNDC1
|
RUN domain containing 1 |
chr2_-_213403565 | 3.45 |
ENST00000342788.4
ENST00000436443.1 |
ERBB4
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
chr15_-_64648273 | 3.44 |
ENST00000607537.1
ENST00000303052.7 ENST00000303032.6 |
CSNK1G1
|
casein kinase 1, gamma 1 |
chr20_+_8112824 | 3.38 |
ENST00000378641.3
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific) |
chr20_+_4666882 | 3.34 |
ENST00000379440.4
ENST00000430350.2 |
PRNP
|
prion protein |
chr6_+_96463840 | 3.31 |
ENST00000302103.5
|
FUT9
|
fucosyltransferase 9 (alpha (1,3) fucosyltransferase) |
chr1_+_151584544 | 3.28 |
ENST00000458013.2
ENST00000368843.3 |
SNX27
|
sorting nexin family member 27 |
chr5_-_107006596 | 3.25 |
ENST00000333274.6
|
EFNA5
|
ephrin-A5 |
chr18_+_10454594 | 3.23 |
ENST00000355285.5
|
APCDD1
|
adenomatosis polyposis coli down-regulated 1 |
chr9_-_91793675 | 3.22 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
chr5_-_32313019 | 3.18 |
ENST00000280285.5
ENST00000264934.5 |
MTMR12
|
myotubularin related protein 12 |
chr13_+_111365602 | 3.18 |
ENST00000333219.7
|
ING1
|
inhibitor of growth family, member 1 |
chr1_-_6240183 | 3.17 |
ENST00000262450.3
ENST00000378021.1 |
CHD5
|
chromodomain helicase DNA binding protein 5 |
chr4_+_115519577 | 3.07 |
ENST00000310836.6
|
UGT8
|
UDP glycosyltransferase 8 |
chr18_+_46065393 | 3.04 |
ENST00000256413.3
|
CTIF
|
CBP80/20-dependent translation initiation factor |
chr21_+_45285050 | 2.99 |
ENST00000291572.8
|
AGPAT3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr10_-_735553 | 2.96 |
ENST00000280886.6
ENST00000423550.1 |
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
chr12_+_108908962 | 2.91 |
ENST00000552695.1
ENST00000552758.1 ENST00000361549.2 |
FICD
|
FIC domain containing |
chr13_-_21476900 | 2.90 |
ENST00000400602.2
ENST00000255305.6 |
XPO4
|
exportin 4 |
chr6_-_111136513 | 2.89 |
ENST00000368911.3
|
CDK19
|
cyclin-dependent kinase 19 |
chr15_-_34502278 | 2.88 |
ENST00000559515.1
ENST00000256544.3 ENST00000560108.1 ENST00000559462.1 |
KATNBL1
|
katanin p80 subunit B-like 1 |
chr6_-_88876058 | 2.83 |
ENST00000369501.2
|
CNR1
|
cannabinoid receptor 1 (brain) |
chr3_-_53080047 | 2.82 |
ENST00000482396.1
ENST00000358080.2 ENST00000296295.6 ENST00000394752.3 |
SFMBT1
|
Scm-like with four mbt domains 1 |
chr12_-_26278030 | 2.82 |
ENST00000242728.4
|
BHLHE41
|
basic helix-loop-helix family, member e41 |
chr3_+_57261743 | 2.81 |
ENST00000288266.3
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
chr2_-_182545603 | 2.81 |
ENST00000295108.3
|
NEUROD1
|
neuronal differentiation 1 |
chr6_+_69345166 | 2.81 |
ENST00000370598.1
|
BAI3
|
brain-specific angiogenesis inhibitor 3 |
chr11_+_33278811 | 2.78 |
ENST00000303296.4
ENST00000379016.3 |
HIPK3
|
homeodomain interacting protein kinase 3 |
chr14_-_91526922 | 2.78 |
ENST00000418736.2
ENST00000261991.3 |
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
chr10_+_86088381 | 2.77 |
ENST00000224756.8
ENST00000372088.2 |
CCSER2
|
coiled-coil serine-rich protein 2 |
chr1_+_12290121 | 2.77 |
ENST00000358136.3
ENST00000356315.4 |
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr17_+_47865917 | 2.76 |
ENST00000259021.4
ENST00000454930.2 ENST00000509773.1 ENST00000510819.1 ENST00000424009.2 |
KAT7
|
K(lysine) acetyltransferase 7 |
chr6_-_91006461 | 2.76 |
ENST00000257749.4
ENST00000343122.3 ENST00000406998.2 ENST00000453877.1 |
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr11_-_30038490 | 2.75 |
ENST00000328224.6
|
KCNA4
|
potassium voltage-gated channel, shaker-related subfamily, member 4 |
chr17_-_62340581 | 2.74 |
ENST00000258991.3
ENST00000583738.1 ENST00000584379.1 |
TEX2
|
testis expressed 2 |
chr13_-_95364389 | 2.73 |
ENST00000376945.2
|
SOX21
|
SRY (sex determining region Y)-box 21 |
chr18_+_13218769 | 2.71 |
ENST00000399848.3
ENST00000361205.4 |
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4 |
chr17_+_41177220 | 2.65 |
ENST00000587250.2
ENST00000544533.1 |
RND2
|
Rho family GTPase 2 |
chr17_+_5031687 | 2.60 |
ENST00000250066.6
ENST00000304328.5 |
USP6
|
ubiquitin specific peptidase 6 (Tre-2 oncogene) |
chr22_-_22221900 | 2.60 |
ENST00000215832.6
ENST00000398822.3 |
MAPK1
|
mitogen-activated protein kinase 1 |
chr4_-_122854612 | 2.59 |
ENST00000264811.5
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3 |
chr9_-_27529726 | 2.58 |
ENST00000262244.5
|
MOB3B
|
MOB kinase activator 3B |
chr12_-_51611477 | 2.57 |
ENST00000389243.4
|
POU6F1
|
POU class 6 homeobox 1 |
chr17_-_4167142 | 2.56 |
ENST00000570535.1
ENST00000574367.1 ENST00000341657.4 ENST00000433651.1 |
ANKFY1
|
ankyrin repeat and FYVE domain containing 1 |
chr10_-_1779663 | 2.54 |
ENST00000381312.1
|
ADARB2
|
adenosine deaminase, RNA-specific, B2 (non-functional) |
chr16_-_18812746 | 2.51 |
ENST00000546206.2
ENST00000562819.1 ENST00000562234.2 ENST00000304414.7 ENST00000567078.2 |
ARL6IP1
RP11-1035H13.3
|
ADP-ribosylation factor-like 6 interacting protein 1 Uncharacterized protein |
chr5_-_160973649 | 2.51 |
ENST00000393959.1
ENST00000517547.1 |
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
chr18_+_43914159 | 2.48 |
ENST00000588679.1
ENST00000269439.7 ENST00000543885.1 |
RNF165
|
ring finger protein 165 |
chr7_-_123389104 | 2.48 |
ENST00000223023.4
|
WASL
|
Wiskott-Aldrich syndrome-like |
chr2_-_70780770 | 2.48 |
ENST00000444975.1
ENST00000445399.1 ENST00000418333.2 |
TGFA
|
transforming growth factor, alpha |
chr6_+_46097711 | 2.43 |
ENST00000321037.4
|
ENPP4
|
ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) |
chr16_-_69419871 | 2.42 |
ENST00000603068.1
ENST00000254942.3 ENST00000567296.2 |
TERF2
|
telomeric repeat binding factor 2 |
chr10_-_126432619 | 2.40 |
ENST00000337318.3
|
FAM53B
|
family with sequence similarity 53, member B |
chr17_-_56406117 | 2.35 |
ENST00000268893.6
ENST00000355701.3 |
BZRAP1
|
benzodiazepine receptor (peripheral) associated protein 1 |
chr1_+_101702417 | 2.33 |
ENST00000305352.6
|
S1PR1
|
sphingosine-1-phosphate receptor 1 |
chr8_+_59323823 | 2.33 |
ENST00000399598.2
|
UBXN2B
|
UBX domain protein 2B |
chr12_+_54402790 | 2.33 |
ENST00000040584.4
|
HOXC8
|
homeobox C8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 30.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
3.1 | 9.2 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
2.9 | 8.8 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
2.8 | 8.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
2.7 | 8.1 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
2.6 | 23.6 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
2.6 | 10.3 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
2.1 | 10.7 | GO:0097338 | response to clozapine(GO:0097338) |
2.0 | 8.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.9 | 7.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.8 | 5.4 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
1.8 | 3.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
1.7 | 5.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.7 | 8.5 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.5 | 5.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.4 | 11.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.4 | 5.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.3 | 4.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.3 | 7.9 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.3 | 3.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.3 | 5.0 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
1.2 | 13.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 4.8 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
1.2 | 11.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.2 | 3.5 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
1.2 | 11.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.1 | 3.4 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
1.1 | 7.9 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
1.1 | 3.4 | GO:0090427 | activation of meiosis(GO:0090427) |
1.1 | 3.3 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
1.1 | 4.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.0 | 7.0 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
1.0 | 3.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 9.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.9 | 2.8 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.9 | 5.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.9 | 8.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 1.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.9 | 17.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.9 | 9.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.9 | 2.6 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.9 | 4.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.8 | 6.7 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.8 | 13.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 2.4 | GO:0031627 | telomeric loop formation(GO:0031627) negative regulation of t-circle formation(GO:1904430) |
0.8 | 4.0 | GO:0051029 | rRNA transport(GO:0051029) |
0.8 | 2.4 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.8 | 2.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.8 | 13.8 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.8 | 4.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.7 | 8.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.7 | 8.8 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.7 | 5.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 2.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.7 | 2.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.7 | 6.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.7 | 2.0 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.7 | 7.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.6 | 9.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.6 | 1.9 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.6 | 2.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.6 | 1.2 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.6 | 9.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 2.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.6 | 2.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
0.5 | 1.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.5 | 2.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.5 | 8.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 2.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.5 | 2.0 | GO:2000672 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 1.5 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.5 | 0.5 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.5 | 7.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.5 | 1.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B cell proliferation involved in immune response(GO:0002322) |
0.5 | 3.3 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.5 | 3.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.5 | 4.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.5 | 3.2 | GO:0098532 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) histone H3-K27 trimethylation(GO:0098532) |
0.5 | 1.8 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.5 | 4.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 1.8 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.4 | 3.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.4 | 2.6 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.4 | 2.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.4 | 0.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.4 | 11.0 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.4 | 3.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 1.9 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.4 | 2.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.4 | 9.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.4 | 1.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 1.1 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.3 | 0.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.3 | 2.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 6.5 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.3 | 10.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 2.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 1.0 | GO:1904954 | Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.3 | 1.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 2.2 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.3 | 0.9 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 8.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 6.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 4.2 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.3 | 1.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 2.0 | GO:0042426 | choline catabolic process(GO:0042426) |
0.3 | 3.3 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.3 | 0.3 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.3 | 9.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 0.8 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 4.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 6.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.2 | 4.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 6.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.3 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.2 | 1.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 3.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 1.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.2 | 5.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 16.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 1.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 8.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.2 | 1.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 4.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 4.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 18.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 0.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.2 | 2.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 4.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 2.8 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 12.7 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.2 | 8.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 1.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 2.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 1.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 1.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 2.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.7 | GO:1903974 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of glial cell migration(GO:1903977) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 6.4 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.1 | 4.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 6.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.8 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 2.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 2.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 1.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 11.8 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 2.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 3.9 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 5.3 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 3.6 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.7 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 5.8 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.1 | 0.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 2.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 2.3 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 1.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 1.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 1.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 2.4 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 0.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 1.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 3.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 3.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 7.7 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 2.9 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 4.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.8 | GO:1900016 | negative regulation of fibroblast migration(GO:0010764) negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 1.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 2.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 7.3 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 1.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 3.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 4.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 2.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 1.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 4.3 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.1 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 6.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.1 | 2.4 | GO:0050820 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
0.1 | 3.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 2.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 1.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 3.7 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.1 | 1.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 1.1 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 1.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 2.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 2.8 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 1.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 1.9 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 1.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.6 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.0 | 4.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.5 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 3.8 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 2.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.3 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 2.0 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.0 | 0.9 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.5 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.2 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 1.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 30.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
3.4 | 10.3 | GO:0044305 | calyx of Held(GO:0044305) |
2.8 | 8.3 | GO:0019034 | viral replication complex(GO:0019034) |
2.0 | 8.1 | GO:0070695 | FHF complex(GO:0070695) |
2.0 | 13.9 | GO:0032584 | growth cone membrane(GO:0032584) |
1.4 | 23.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.3 | 3.9 | GO:0097443 | sorting endosome(GO:0097443) |
1.3 | 8.8 | GO:0001520 | outer dense fiber(GO:0001520) |
1.1 | 4.6 | GO:0031417 | NatC complex(GO:0031417) |
1.1 | 8.8 | GO:0036157 | outer dynein arm(GO:0036157) |
1.0 | 4.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.9 | 4.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 6.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.8 | 10.3 | GO:0097433 | dense body(GO:0097433) |
0.8 | 13.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.7 | 2.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.6 | 8.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 5.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.6 | 1.7 | GO:0034657 | GID complex(GO:0034657) |
0.5 | 10.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 11.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 4.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.5 | 6.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 3.3 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 12.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 1.3 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.4 | 2.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 6.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 4.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 4.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 1.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 2.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 2.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 4.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 11.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 7.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.3 | 20.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 0.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 8.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 5.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 1.4 | GO:0031905 | early endosome lumen(GO:0031905) |
0.3 | 4.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 6.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 5.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 5.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 7.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.2 | 4.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 2.5 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 17.9 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 5.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 3.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 4.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 5.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 21.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 1.0 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.1 | 2.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.6 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 5.2 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 2.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 3.7 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 7.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 2.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 2.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 11.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 3.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 2.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 4.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 4.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 1.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 11.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 2.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 6.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 8.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 2.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 3.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 4.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 5.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 11.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 1.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 1.8 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 7.8 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 5.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 1.3 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 4.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 1.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 2.8 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 4.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 1.9 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 1.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 2.3 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.4 | GO:0002102 | podosome(GO:0002102) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
3.1 | 9.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
2.2 | 67.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.9 | 3.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.9 | 5.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.7 | 11.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.7 | 10.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.6 | 9.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.5 | 4.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
1.4 | 5.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.4 | 13.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.3 | 6.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.3 | 6.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.2 | 15.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
1.1 | 3.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.1 | 9.6 | GO:0000182 | rDNA binding(GO:0000182) |
1.1 | 6.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.0 | 11.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.0 | 11.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 5.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.0 | 5.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.9 | 2.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.9 | 9.2 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.9 | 7.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.8 | 10.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.8 | 13.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.8 | 4.8 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.8 | 3.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.7 | 8.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.7 | 7.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.7 | 10.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 8.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 7.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 6.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.6 | 3.3 | GO:1903135 | cupric ion binding(GO:1903135) |
0.6 | 1.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 7.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.5 | 3.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 1.5 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.5 | 4.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.5 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 2.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 8.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 1.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 7.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 3.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 2.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 11.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 4.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 8.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 2.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 3.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 5.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 3.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 6.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 2.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 4.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 1.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.9 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.3 | 8.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 4.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 2.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 8.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 5.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 1.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 1.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 22.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 1.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 5.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 7.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 3.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 4.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 2.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 5.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 11.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 3.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 8.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 2.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.2 | 2.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 2.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 2.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 4.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 4.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 2.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 3.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 6.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 3.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 3.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 6.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 2.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 1.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 1.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 22.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 5.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 1.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 8.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 3.7 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 2.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 1.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 6.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 4.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 4.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 3.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 2.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 2.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 8.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 6.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 2.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 17.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 2.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 4.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 3.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 1.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 2.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 7.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.1 | GO:0004882 | androgen receptor activity(GO:0004882) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.6 | 6.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 10.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 21.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 16.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 16.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 6.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 10.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 4.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 10.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 11.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 5.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 1.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 6.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 7.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 6.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 8.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 9.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 3.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 5.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 7.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 2.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 4.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 5.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 3.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 2.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 3.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 2.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 30.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.0 | 4.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.5 | 7.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 5.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 9.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 8.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 10.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 3.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 5.8 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 10.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 4.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 6.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 7.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 4.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 5.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 4.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 2.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 10.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 5.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 9.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 9.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 7.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 4.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 10.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 7.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 4.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 9.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 7.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 3.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 3.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 2.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 12.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 5.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 4.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 10.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 3.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 5.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 1.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 1.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 2.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |